Table 2.
Characteristics | Overall | STI− | STI+* | P value |
---|---|---|---|---|
N = 2236 (%) | N = 1744 (%) | N = 492 (%) | ||
Age | <0.001 | |||
<23 years | 660 (30) | 477 (28) | 183 (37) | |
23–27 years | 484 (22) | 376 (22) | 108 (22) | |
28–32 years | 564 (25) | 454 (26) | 110 (22) | |
38+ years | 528 (24) | 437 (25) | 91 (19) | |
Education | 0.584 | |||
At least high school | ||||
No | 1550 (69) | 1204 (69) | 346 (70) | |
Yes | 686 (30) | 540 (31) | 146 (30) | |
Regular income/employment | 0.212 | |||
No | 1842 (82) | 1446 (83) | 396 (80) | |
Yes | 394 (18) | 298 (17) | 96 (20) | |
Sexual behaviour | 0.219 | |||
<3 sexual acts reported in the last 2 weeks | 1282 (57) | 988 (56) | 294 (60) | |
3+ sexual acts reported in the last 2 weeks | 954 (43) | 756 (43) | 198 (40) | |
Condom use at last sex act | 0.221 | |||
No | 896 (40) | 687 (39) | 209 (42) | |
Yes | 1339 (60) | 1056 (60) | 283 (57) | |
Hormonal contraceptiona | 0.75 | |||
No | 845 (37) | 662 (37) | 183 (37) | |
Yes | 1391 (62) | 1082 (62) | 309 (62) |
*At least one positive test for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and T. pallidum at enrolment.
aincludes injectable and oral contraception.